Douglas W. Pagan Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Douglas W. Pagan.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Douglas W. Pagan. Douglas W. Pagan is a Director in ZIOPHARM ONCOLOGY INC ($ZIOP) and a Chief Financial Officer in Paratek Pharmaceuticals, Inc. ($PRTK) and a Chief Financial Officer in Dicerna Pharmaceuticals Inc ($DRNA).
Address: C/O PARATEK PHARMACEUTICALS, INC. 75 KNEELAND STREET BOSTON 02111 MA
Companies in which Douglas W. Pagan is an Insider
Dicerna Pharmaceuticals Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Douglas W. Pagan: Chief Financial Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jan 12 2021
$DRNA Market Capitalization: $50.84M
$DRNA Previous Close: $2.58
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Paratek Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Douglas W. Pagan: Chief Financial Officer
Holdings: 151,557 shares
Current Value: $2,311,244
Latest Transaction: Apr 08 2019
$PRTK Market Capitalization: $346.19M
$PRTK Previous Close: $15.25
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ZIOPHARM ONCOLOGY INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Douglas W. Pagan: Director
Holdings: 55,997 shares
Current Value: $375,180
Latest Transaction: Jan 03 2020
$ZIOP Market Capitalization: $850.83M
$ZIOP Previous Close: $6.70
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Douglas W. Pagan
Sentiment: All, DRNA, PRTK, ZIOP
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 12 2021 | DRNA | Dicerna Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Option Exercise | A | 24.05 | 36,900 | 887,445 | 36,900 | |
| Jan 12 2021 | DRNA | Dicerna Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Option Exercise | A | 0.00 | 8,200 | 0 | 8,200 | |
| Jun 02 2020 | DRNA | Dicerna Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Option Exercise | A | 20.79 | 95,650 | 1,988,564 | 95,650 | |
| Jun 02 2020 | DRNA | Dicerna Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Option Exercise | A | 0.00 | 27,300 | 0 | 27,300 | |
| Jan 03 2020 | ZIOP | ZIOPHARM ONCOLOGY ... | Pagan Douglas W. | Director | Option Exercise | A | 4.72 | 25,281 | 119,326 | 25,281 | |
| Jan 03 2020 | ZIOP | ZIOPHARM ONCOLOGY ... | Pagan Douglas W. | Director | Payment of Exercise | F | 4.72 | 20,054 | 94,655 | 35,943 | 56 K to 35.9 K (-35.81 %) |
| Jan 03 2020 | ZIOP | ZIOPHARM ONCOLOGY ... | Pagan Douglas W. | Director | Grant | A | 0.00 | 15,890 | 0 | 55,997 | 40.1 K to 56 K (+39.62 %) |